Howard M O, Cottler L B, Compton W M, Ben-Abdallah A
Department of Psychiatric Epidemiology and George Warren Brown School of Social Work, Campus Box 1196, One Brookings Drive, Washington University, St Louis, MO 63105, USA.
Drug Alcohol Depend. 2001 Feb 1;61(3):223-8. doi: 10.1016/s0376-8716(00)00151-4.
The diagnostic concordance of DSM-III-R, DSM-IV, and ICD-10 inhalant use disorders was assessed using the sample of lifetime inhalant users (n=76) participating in the DSM-IV Field Trial for Substance Use Disorders. Substantially smaller proportions of lifetime inhalant users met DSM-IV inhalant abuse or dependence criteria than met comparable DSM-III-R or ICD-10 criteria. DSM-III-R and ICD-10 performed similarly, although DSM-III-R tended to be more inclusive vis-à-vis diagnoses of inhalant dependence. Kappa coefficients indicated a moderate degree of concordance between the three nosologies for inhalant use disorder diagnosis rates. Inclusion of possible withdrawal symptomatology criteria (that are not normally included) in the DSM-IV and ICD-10 criteria sets for inhalant dependence exerted little effect on diagnosis rates.
使用参与物质使用障碍DSM-IV现场试验的终生吸入剂使用者样本（n = 76），评估了DSM-III-R、DSM-IV和ICD-10吸入剂使用障碍的诊断一致性。与符合类似的DSM-III-R或ICD-10标准的终生吸入剂使用者相比，符合DSM-IV吸入剂滥用或依赖标准的比例要小得多。DSM-III-R和ICD-10的表现相似，尽管DSM-III-R在吸入剂依赖诊断方面往往更具包容性。卡帕系数表明，三种分类法在吸入剂使用障碍诊断率方面存在中度一致性。在DSM-IV和ICD-10吸入剂依赖标准集中纳入可能的戒断症状标准（通常不包括在内）对诊断率影响不大。
